HealthcareHow Do Pharmaceutical Companies Engage Patient Advocacy Groups (PAGs) in Emerging Markets?
Speyside Group provides a strategic perspective on patient advocacy group engagement in emerging markets, examining how multinational pharmaceutical companies structure compliant, locally embedded partnerships across Latin America, Asia, and Africa. Drawing on cases from Brazil, India, and Ghana, the analysis outlines the funding caps, disclosure practices, and neutral-channel strategies that separate durable market access programs from reputational and regulatory risk.
Read more